Clinical Site

Montreal, Quebec H4A 2C6

1 studies enrolling now · 5 studies all time

What they study most

Cardiovascular Disease, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Elevated Lipoprotein(a), Fatty Liver, Nonalcoholic, Hidradenitis Suppurativa, Hypertriglyceridemia, NAFLD

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa — Enrolling by invitation
• Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD) — Completed
• Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease — Completed
• Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease — Completed